17
Jan
2024
WASHINGTON - Our pharmacy organizations are deeply concerned about FDA’s recent authorization of a state drug importation program, which could open the door for harmful and counterfeit drugs to enter our nation’s drug supply, with no evidence that this will result in cost savings for our patients.
Categories: Press Releases
Tags: Press Releases, press release
8
WASHINGTON, DC—The American Pharmacists Association (APhA) announced the slate of candidates for its board of trustees, president-elect, and honorary president today. The elections for these positions will be held March 22, 2024, through May 6, 2024
21
Dec
2023
WASHINGTON, DC – Today, The American Society for Consultant Pharmacists (ASCP) and the American Pharmacists Association (APhA) announced a partnership beginning January 1, 2024, to build a professional development program for recertification of Board-Certified Geriatric Pharmacists (BCGP) by the Board of Pharmacy Specialties (BPS).
WASHINGTON, DC—The American Pharmacists Association (APhA) announced today that it has entered into a contracted project agreement with CDC’s Applied Research and Evaluation Branch in the Division for Heart Disease and Stroke Prevention to accelerate the implementation of pharmacy-based strategies to advance health equity and prevent heart disease and stroke.
WASHINGTON, DC—The American Pharmacists Association (APhA) Foundation is honored to announce Thomas R. Temple, BS, MS, as the 2024 recipient of the Jacob W. Miller Award.